Image

Effect of Modified Air-pulse Stimulation on Tracheotomised Patients With Dysphagia After Stroke

Effect of Modified Air-pulse Stimulation on Tracheotomised Patients With Dysphagia After Stroke

Recruiting
30-80 years
All
Phase N/A

Powered by AI

Overview

To evaluate the efficacy of flexible endoscopy-mediated modified air-pulse stimulation in restoring of swallowing function in this group of patients.Forty-two subacute stroke patients with tracheotomy and dysphagia need to be recruited and divided into a control group of 21 cases and a trial group of 21 cases. On the basis of receiving personalized swallowing rehabilitation training, the control group received traditional air-pulse stimulation therapy, while the trial group received modified air-pulse stimulation therapy mediated by flexible endoscopy. Murray secretion scale (MSS), penetration-aspiration scale (PAS) and spontaneous swallowing frequency were used to assess dysphagia. Moreover, clinical pulmonary infection score (CPIS) was used for evaluating the degree of pneumonia, hemoglobin(Hb) and serum prealbumin (PAB) were used to assess the nutritional status of patients.

Eligibility

Inclusion Criteria:

  • patients who met the diagnostic criteria for stroke formulated in the 4th National Academic Conference on Cerebrovascular disease;
  • patients with relatively stable vital signs, with a NIHSS score of 21 points;
  • patients with tracheotomy accompanied by dysphagia;
  • no previous history of dysphagia;
  • age ≥ 30 years and ≤80 years;
  • informed consent signed by the patient and his family.

Exclusion Criteria:

  • patients with medullary haemorrhage/infarction;
  • patients that experienced cerebral hernia and recurrent stroke;
  • patients with unstable arrhythmia, fever, infection, severe restlessness and inability to cooperate with treatment;
  • patients with gastro-oesophageal reflux, bilateral paralysis of the vocal cord, laryngopharyngeal stenosis/haemorrhage/tumour;
  • patients in which there was an inability to accurately locate epiglottis and arytenoid cartilage due to throat disease;
  • patients with a history of epilepsy or risk of seizures.

Study details
    Stroke

NCT06299904

The Second Affiliated Hospital of Dalian Medical University

19 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.